According to the report, the global biomaterials market is projected to expand from USD 40.8 billion in 2025 to USD 78.8 billion by 2035, registering a CAGR of 6.8%, the highest during the forecast period. Biomaterials market is growing because of the rising needs of sophisticated implantable devices in orthopedics, cardiovascular care and dental use including the help of the aging populations and rising cases of chronic diseases. Constant development of bioresorbable polymer, recombinant collagen, 3D-printable bioinks, and bioactive ceramics is facilitating improved biocompatibility, accelerated healing, and increased life of implants.
Minimal invasive surgery operations and outpatient surgeries are growing faster, which mean that high-performance, lightweight, and patient-specific materials are increasingly in use. The developments of regenerative medicine and tissue engineering are establishing new commercial opportunities of scaffolds and extracellular matrices. Low-carbon, biodegradable, bio-based polymers are also being developed due to sustainability efforts in accordance with the decarbonization of healthcare.
The development of healthcare systems in the emerging markets and better regulatory channels through innovative materials are also facilitating commercialization and internationalization of next-generation biomaterial platforms. All of this is causing faster technology differentiation and more high-value clinical uses which are bolstering future growth in the market.
“Key Driver, Restraint, and Growth Opportunity Shaping the Global Biomaterials Market”
The rising interest in precision medicine and targeted therapeutics is increasing the need to use advanced biomaterials in controlled drug delivery systems. Sustained release of drugs using biodegradable polymers, hydrogels, liposomal carriers, polymeric microspheres makes therapeutic efficient and reduces systemic hypotoxicity. Oncology, diabetes, and chronic inflammatory diseases are becoming more widespread and this encourages implantable and injectable biomaterial-based delivery platforms in healthcare systems across the world.
High-performance biomaterials are developed based on research, rigorous biocompatibility tests, dedicated clean rooms, and under the strict regulatory environment. The use of advanced processing techniques like the manufacture of polymers, surface modification, and precise manufacturing further raise the capital cost. These are cost overheads that can restrict accessibility especially in the emerging markets and provide pricing pressures that decelerate the commercialization of novel biomaterial solutions on a large scale.
The break-neck development in bioelectronics is providing means to develop bio-materials that can be easily integrated with sensors, electrodes, and microelectronic elements. Conductive polymers, bioactive surfaces, and flexible substrates increase tissue compliance and allow real time monitoring and therapeutic feedback. The increasing need to use smart implants in the neurology, cardiology and chronic disease management fields, is driving the efforts to develop multifunctional biomaterials that can provide both structural and digital health support.
Regional Analysis of Global Biomaterials Market
Prominent players operating in the global biomaterials market are BASF SE, 3M Company, Abbott Laboratories, Berkeley Advanced Biomaterials, CAM Bioceramics B.V., Celanese Corporation, CeramTec GmbH, CoorsTek Inc., Corbion NV, Covestro AG, Dentsply Sirona, DuPont de Nemours, Inc., Evonik Industries AG, GELITA AG, Invibio Ltd., Johnson & Johnson, Koninklijke DSM N.V., Medtronic plc, Mitsubishi Chemical Corporation, Stryker Corporation, Terumo Corporation, Victrex plc, Zimmer Biomet Holdings, Inc., and Other Key Players.
The global biomaterials market has been segmented as follows:
Global Biomaterials Market Analysis, By Material Type
Global Biomaterials Market Analysis, By Origin
Global Biomaterials Market Analysis, By Biodegradability
Global Biomaterials Market Analysis, By Application
Global Biomaterials Market Analysis, By Form
Global Biomaterials Market Analysis, By End-users
Global Biomaterials Market Analysis, By Region
About Us
MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.
Contact Us
USA Address:
800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.
+1(302)303-2617
info@marketgenics.co
India Address:
3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.
sales@marketgenics.co
Table of Contents
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
We will customise the research for you, in case the report listed above does not meet your requirements.
Get 10% Free Customisation